Copley Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,092
Closed -$275K – 86
2026
Q2
$275K Sell
1,092
-673
-38% -$145K 0.17% 88
2026
Q1
$384K Sell
1,765
-124
-7% -$27.5K 0.23% 76
2025
Q4
$432K Sell
1,889
-256
-12% -$58.3K 0.27% 60
2025
Q3
$497K Sell
2,145
-105
-5% -$21.4K 0.34% 50
2025
Q2
$418K Sell
2,250
-244
-10% -$45.3K 0.31% 67
2025
Q1
$523K Sell
2,494
-100
-4% -$19.4K 0.4% 53
2024
Q4
$461K Buy
2,594
+119
+5% +$21.9K 0.35% 64
2024
Q3
$489K Buy
+2,475
New +$462K 0.44% 52

Other funds holding ABBV

Copley Financial Group's ABBV Position: Q3 2026 in Review

Copley Financial Group sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 1,092 shares — an estimated $275K sold.

Copley Financial Group first reported a position in ABBV in Q3 2024 and held it in 8 quarters. The position peaked at $523K in Q1 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Copley Financial Group reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Copley Financial Group sold 1,092 AbbVie shares in Q3 2026, an estimated $275K.
  • Copley Financial Group first reported a position in AbbVie in Q3 2024 and held it in 8 quarters.
  • Copley Financial Group's AbbVie position peaked at $523K in Q1 2025.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Copley Financial Group's 13F filing for Q3 2026, filed 16 Nov 2026.